• Who We Are

    FusionBio, Inc. is a biopharmaceutical company developing novel treatments for immune mediated diseases including cancer and autoimmunity.
  • 1
  • What We Offer
  • The FusionBio Advantage
The FusioBio technology generates stable covalent trimers of tumor necrosis factor superfamily ligands to be used alone or in combination immunotherapy with other agents.
The FusionBio technology is unique in that it creates stable trimeric ligands with potent activity but without any external additions or introduced immunogenicity problems.